BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1146651)

  • 1. Relationship between animal models and clinical parkinsonism.
    Marsden CD; Duvoisin RC; Jenner P; Parkes JD; Pycock C; Tarsy D
    Adv Neurol; 1975; 9():165-75. PubMed ID: 1146651
    [No Abstract]   [Full Text] [Related]  

  • 2. [The reserpine model of parkinsonism and changes in the metabolism of mediators].
    Tret'iakova KA; Samoĭlova ZT
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):220-4. PubMed ID: 4743272
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neurons.
    Ungerstedt U; Ljungberg T; Steg G
    Adv Neurol; 1974; 5():421-6. PubMed ID: 4531217
    [No Abstract]   [Full Text] [Related]  

  • 4. [L-threo-DOPS therapy and parkinsonism].
    Narabayashi H
    No To Shinkei; 1986 Jan; 38(1):60-2. PubMed ID: 3083844
    [No Abstract]   [Full Text] [Related]  

  • 5. Parkinsonism: animal analogues of the human disorder.
    Duvoisin RC
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():293-303. PubMed ID: 826997
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
    Murer MG; Dziewczapolski G; Menalled LB; García MC; Agid Y; Gershanik O; Raisman-Vozari R
    Ann Neurol; 1998 May; 43(5):561-75. PubMed ID: 9585350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic agonists in animal models of parkinsonism.
    Poirier LJ
    Adv Neurol; 1975; 9():327-35. PubMed ID: 807089
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-induced changes in brain dopamine and their relation to parkinsonism.
    Vogt M
    Sci Basis Med Annu Rev; 1970; ():276-91. PubMed ID: 4319923
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemical and pharmacological aspects of Parkinsonism.
    Carlsson A
    Acta Neurol Scand Suppl; 1972; 51():11-42. PubMed ID: 4351191
    [No Abstract]   [Full Text] [Related]  

  • 10. [Modeling parkinsonism (review)].
    Atadzhanov M
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(3):110-9. PubMed ID: 6805182
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biochemical bases of Parkinson disease].
    Colucci d'Amato C; Puccini A; Cristillo A; Vizioli R
    Recenti Prog Med; 1984 Oct; 75(10):889-901. PubMed ID: 6151219
    [No Abstract]   [Full Text] [Related]  

  • 12. [Parkinsonism induced by MPTP as an experimental model of Parkinson disease: similarities and differences].
    Luquin MR; Obeso JA; Herrero MT; Laguna J; Martínez-Lage JM
    Neurologia; 1991 Oct; 6(8):287-94. PubMed ID: 1790005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nigral and adrenal grafts in parkinsonism: recent basic and clinical studies.
    Olson L; Backlund EO; Gerhardt G; Hoffer B; Lindvall O; Rose G; Seiger A; Strömberg I
    Adv Neurol; 1987; 45():85-94. PubMed ID: 3030073
    [No Abstract]   [Full Text] [Related]  

  • 14. Trophism, transplantation, and animal models of Parkinson's disease.
    Bankiewicz K; Mandel RJ; Sofroniew MV
    Exp Neurol; 1993 Nov; 124(1):140-9. PubMed ID: 8282071
    [No Abstract]   [Full Text] [Related]  

  • 15. Physiologic, biochemical, and pathological backgrounds of levodopa and possibilities for the future.
    Hornykiewicz OD
    Neurology; 1970 Dec; 20(12):1-5. PubMed ID: 5531292
    [No Abstract]   [Full Text] [Related]  

  • 16. [Modeling of certain symptoms of parkinsonism].
    Samoĭlova ZT; Petelin LS; Tret'iakova KA; Chechulin IuS
    Patol Fiziol Eksp Ter; 1973; 17(4):78-80. PubMed ID: 4776275
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopaminergic and cholinergic mechanisms in relation to postural tremor in the monkey and circling movements in the cat.
    Poirier LJ; Langelier P; Bédard P; Boucher R; Larochelle L; Parent A; Roberge AG
    Adv Neurol; 1974; 5():5-10. PubMed ID: 4216259
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental neuropathy with Parkinson-like muscular rigidity. A suitable model for testing dopaminergic agonists and neuroleptic drugs.
    Halbhübner K; Herken H; Loos D
    Arzneimittelforschung; 1978; 28(10):1743-52. PubMed ID: 39569
    [No Abstract]   [Full Text] [Related]  

  • 19. N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the monkey: neurochemical pathology and regional brain metabolism.
    Mitchell IJ; Cross AJ; Sambrook MA; Crossman AR
    J Neural Transm Suppl; 1986; 20():41-6. PubMed ID: 3462325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unilateral MPTP-induced parkinsonism in monkeys. A quantitative autoradiographic study of dopamine D1 and D2 receptors and re-uptake sites.
    Przedborski S; Jackson-Lewis V; Popilskis S; Kostic V; Levivier M; Fahn S; Cadet JL
    Neurochirurgie; 1991; 37(6):377-82. PubMed ID: 1780015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.